Semicarbazide-sensitive amine oxidase and mortality in chronic heart failure

European Heart Journal

Volumn 21, Issue 22, 2000, Pages 1812-1814

  Yu, P H ^a  

^a UNIVERSITY OF SASKATCHEWAN   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADVANCED GLYCATION END PRODUCT; ALLYLAMINE; AMINE OXIDASE (COPPER CONTAINING); BENZYLAMINE; FORMALDEHYDE; LOW DENSITY LIPOPROTEIN; METHYLGLYOXAL; SEMICARBAZIDE; VASCULAR ADHESION PROTEIN 1;

ADIPOSE TISSUE CELL; AGING; ATHEROSCLEROSIS; CYTOTOXICITY; DEAMINATION; DIABETES MELLITUS; ENDOTHELIUM; ENZYME BLOOD LEVEL; ENZYME INHIBITION; ENZYMOLOGY; GLYCATION; HEART FAILURE; HUMAN; MORTALITY; OXIDATIVE STRESS; PRIORITY JOURNAL; PROGNOSIS; PROTEIN CROSS LINKING; REVIEW; VASCULAR SMOOTH MUSCLE;

EID: 0033748219     PISSN: 0195668X     EISSN: None     Source Type: Journal    
DOI: 10.1053/euhj.2000.2276     Document Type: Review

References (15)

1. Plasma semicarbazide-sensitive amine oxidase (SSAO) is an independent prognostic marker for mortality in chronic heart failure
2. Deamination of methylamine and angiopathy; toxicity of formaldehyde, oxidative stress and relevance to protein glycoxidation in diabetes
3. Role of semicarbazide-sensitive amine oxidase on glucose transport and GLUT4 recruitment to the cell surface in adipose cells
4. Developmental vasculotoxicity associated with inhibition of semicarbazide-sensitive amine oxidase
5. Cloning of vascular adhesion protein a; Reveals a novel multifunctional adhesion molecule
6. Circulating form of human vascular adhesion protein-1 (VAP-1): Increased serum levels in inflammatory liver diseases
7. Allylamine cardiovascular toxicity
8. Methylamine, a potential endogenous toxin for vascular tissues: Formation of formaldehyde via enzymatic deamination and the cytotoxic effects on endothelial cells
9. Binding and modification of proteins by methylglyoxal under physiological conditions
10. Serum monoamine oxidase in diabetes mellitus and some other internal diseases
11. Plasma semicarbazide-sentive amine oxidase activity is elevated in diabetes mellitus and correlates with glycosylated haemolglobin
12. Elevated serum semicarbazide-sensitive amine oxidase activity in non-insulin-dependent diabetes mellitus: Correlation with BMI and serum triglyceride
13. Elevated plasma semicarbazide-sensitive amine oxidase (SSAO) activity in Type 2 diabetes mellitus complicated by retinopathy
14. Plasma semicarbazide-sensitive amine oxidase is elevated in patients with congestive heart failure
15. Endogenous formaldehyde and vulnerability of atherosclerosis: Involvement of semicarbazide-sensitive amine oxidase-mediated methylamine turnover